Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Adenosine triphosphate (ATP) is the primary energy carrier in all living cells, and its central role in cellular metabolism is well established. The rationale behind using ATP supplementation to address low energy is based on its fundamental biological function: ATP provides the energy required for most cellular processes. Some studies have evaluated the effects of oral or intravenous ATP supplementation on energy levels, physical performance, and recovery, particularly in athletes and patients with certain medical conditions. However, the scientific evidence supporting its efficacy as a treatment for general lack of energy or fatigue is limited and mixed.

Oral ATP is rapidly broken down in the gastrointestinal tract, which raises doubts about its bioavailability and effectiveness when taken as a dietary supplement. A few clinical trials have suggested modest benefits in exercise performance and fatigue reduction, especially in elderly populations or those with specific medical conditions, but results are inconsistent and often limited by small sample sizes and methodological weaknesses. Intravenous ATP has been explored in clinical settings for cancer-related fatigue, with some studies reporting minor improvements, but the overall quality of evidence remains low.

In summary, while the biological importance of ATP is undisputed, robust clinical evidence supporting its supplementation for alleviating general energy deficiency in healthy individuals is lacking. More research is needed to clarify its potential benefits, optimal dosing, and safety profile for this indication.

More about adenosine triphosphate (ATP)
More about Energy (lack of)

Other ingredients used for Energy (lack of)

Other health conditions supported by adenosine triphosphate (ATP)

Products containing adenosine triphosphate (ATP)